Novartis

Novartis, founded in 1996, is a leading global pharmaceutical and healthcare company headquartered in Basel, Switzerland. The company is dedicated to discovering, developing, and manufacturing innovative medicines and healthcare solutions to address unmet medical needs worldwide. With a strong emphasis on research and development, Novartis operates across numerous therapeutic areas, including oncology, immunology, neuroscience, and cardiovascular diseases. Its commitment to scientific advancement drives the creation of novel treatments aimed at improving patient outcomes and quality of life. Learn about Novartis's global headquarters for insights into its strategic operational base.

Operating with a workforce of over 10,000 employees across 105 locations globally, Novartis maintains a significant international footprint. The company's extensive R&D infrastructure supports its mission to pioneer new therapies and enhance existing ones. Novartis's product portfolio includes a wide range of pharmaceuticals, from innovative patented drugs to biosimilars and generic medicines, covering critical areas like cancer treatment and chronic disease management. The company actively engages in collaborations and partnerships to accelerate drug discovery and development. Meet Novartis's team to understand the expertise driving these advancements.

In the competitive landscape of the pharmaceutical industry, Novartis stands alongside major players such as Pfizer, Roche, GSK, AstraZeneca, Merck, and Sanofi. The company generated approximately $56.7 billion in revenue, underscoring its substantial market presence. Novartis's strategic focus on innovation, combined with its broad therapeutic reach and global operational scale, positions it as a key contributor to advancing global health. Its ongoing investment in cutting-edge research and development aims to tackle complex diseases and deliver life-changing treatmentsView more...